Neurosci Lett. 2003 Nov 27;352(1):67-9.

Cerebrospinal fluid markers for prediction of Alzheimer's disease.

Source

Department of Clinical Chemistry and Transfusion Medicine, Sahlgrenska University Hospital, Göteborg University, S-413 45 Gothenburg, Sweden. henrik.zetterberg@clinichem.gu.se

Abstract

A major diagnostic challenge when people seek advice for cognitive dysfunction is to differentiate between mild cognitive impairment (MCI) and incipient Alzheimer's disease (AD). We show that a combination of three cerebrospinal fluid biochemical markers, total-tau, phospho-tau and beta-amyloid(1-42), can detect incipient AD among patients fulfilling the criteria for MCI with a sensitivity of 68% (95% CI 45-86%) and a specificity of 97% (95% CI 83-100%). The usefulness of these markers is further emphasized by the finding of a positive predictive value of 94% and a negative predictive value of 81%.

PMID:: 14615052; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Alzheimer's Disease - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. [JAMA. 2009]
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.
Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, et al. JAMA. 2009 Jul 22; 302(4):385-93.
Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides. [Neurodegener Dis. 2008]
Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.
Höglund K, Hansson O, Buchhave P, Zetterberg H, Lewczuk P, Londos E, Blennow K, Minthon L, Wiltfang J. Neurodegener Dis. 2008; 5(5):268-76. Epub 2008 Feb 29.
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. [Lancet Neurol. 2006]
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.
Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Lancet Neurol. 2006 Mar; 5(3):228-34.
Review Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: beta-amyloid(1-42), tau, phospho-tau-181 and total protein. [Drugs Today (Barc). 2007]
Review Cerebrospinal fluid biomarkers for diagnosis of Alzheimer's disease: beta-amyloid(1-42), tau, phospho-tau-181 and total protein.
Marksteiner J, Hinterhuber H, Humpel C. Drugs Today (Barc). 2007 Jun; 43(6):423-31.
Review Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature. [World J Biol Psychiatry. 2008]
Review Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature.
Diniz BS, Pinto Júnior JA, Forlenza OV. World J Biol Psychiatry. 2008; 9(3):172-82.

See reviews... See all...

Cited by 13 PubMed Central articles

microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). [Int J Biochem Mol Biol. 2012]
microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF).
Alexandrov PN, Dua P, Hill JM, Bhattacharjee S, Zhao Y, Lukiw WJ. Int J Biochem Mol Biol. 2012; 3(4):365-73. Epub 2012 Dec 24.
Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder. [Am J Psychiatry. 2012]
Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder.
Pomara N, Bruno D, Sarreal AS, Hernando RT, Nierenberg J, Petkova E, Sidtis JJ, Wisniewski TM, Mehta PD, Pratico D, et al. Am J Psychiatry. 2012 May; 169(5):523-30.
Review Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play. [Radiology. 2012]
Review Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play.
Jack CR Jr. Radiology. 2012 May; 263(2):344-61.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Cerebrospinal fluid markers for prediction of Alzheimer's disease.
Cerebrospinal fluid markers for prediction of Alzheimer's disease.
Neurosci Lett. 2003 Nov 27 ;352(1):67-9.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Cerebrospinal fluid markers for prediction of Alzheimer's disease.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 13 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information